Topic: Fast Track designation

The regulatory status sets the prodrug of tramiprosate up to speed through the FDA review process if it bucks the trend and hits the mark in phase 3.

Get Wednesday's shot of biopharma news of note.

Germany’s healthcare cost watchdog is continuing to push back against the European Medicines Agency’s plans to accelerate the approval of new medicines.

After posting positive phase 2b data on its lupus nephritis med voclosporin, Aurinia selected Worldwide Clinical Trials as the CRO to conduct the last round of trials before a new drug application.